UNSPSC 51334300: Antipsychotic thioxanthenes

Antipsychotic drugs made from compounds with three aromatic rings in linear arrangement with a SULFUR in the center ring.

UNSPSC 51334300 Antipsychotic thioxanthenes is a Class code that nominally designates a specific psychiatric medication category, but recent state and local procurement activity under this code shows minimal alignment with that narrow pharmaceutical scope. The three most recent opportunities tagged to the code involve naloxone and drug deactivation systems, a direct-to-manufacturer prescription program inquiry, and generic multi-source pharmaceuticals and OTC products — none of which are antipsychotic thioxanthenes. The code appears to be a catch-all or misfiled designation for broader pharmaceutical procurement activity rather than a targeted category for a single drug class. State and local issuing bodies tagging opportunities to this code span county health departments, state health agencies, and multistate cooperative purchasing alliances. The Seminole County, Florida procurement and the Texas Health and Human Services Commission inquiry represent county and state-level health system customers.

Recent procurement activity appears concentrated in Florida, Texas, and the Upper Midwest through multistate vehicles. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, with a July 26, 2023 response deadline, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with awards on a fixed-fee basis and a two-year term plus one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, gathering market intelligence on direct-to-manufacturer prescription programs for state pharmacy benefit plans — a preliminary information-gathering exercise rather than a binding solicitation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026, with a March 26, 2026 response deadline, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers to participating state and local government facilities in Minnesota and Oregon, with awards effective July 1, 2026. The code does not support reliable activity signals for antipsychotic thioxanthenes specifically; businesses pursuing pharmaceutical supply contracts in state and local markets should monitor higher-tier pharmaceutical codes for more relevant opportunities.